Longitudinal profiling reveals a persistent intestinal dysbiosis triggered by conventional anti-tuberculosis therapy/Experiment 26/Signature 1

From BugSigDB
Needs review

Curated date: 2024/11/11

Curator: KateRasheed

Revision editor(s): KateRasheed

Source: Additional file 12: Figure S12

Description: Differentially abundant taxa between the VANM group and Pyrazinamide treatment group.

Abundance in Group 1: increased abundance in Z (Pyrazinamide)

NCBI Quality ControlLinks
Ethanoligenens
Erysipelothrix
Christensenella
Stomatobaculum
Acetanaerobacterium
Anaeroplasma
Anaerotruncus
Guggenheimella
Arthrobacter
Oxobacter
Dorea
Eisenbergiella
Anaerosporobacter
Pseudobacteroides
Marvinbryantia
Acetivibrio
Thomasclavelia
Intestinimonas
Akkermansia
Enterorhabdus
Blautia
Tyzzerella
Acetatifactor
Flavonifractor
Pseudoflavonifractor
Turicibacter
Robinsoniella
Ruminococcus
Hydrogenoanaerobacterium
Romboutsia
Mucispirillum
Gordonibacter
Pelotomaculum
Roseburia
unclassified Eubacterium
Dysgonomonas
Oscillibacter
Erysipelotrichaceae
Alistipes
Coprobacter
Tannerella
Lachnospiraceae
Bacteroides

Revision editor(s): KateRasheed